A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
Conditions: Atopic Dermatitis; Eczema Interventions: Drug: Bermekimab Monoclonal Antibody; Drug: Placebo Sponsor: XBiotech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials